CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Income Quality Over TimeContracting
Percentile Rank92
3Y CAGR+49.3%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
+49.3%/yr
vs +5.7%/yr prior
Acceleration
+43.5pp
Accelerating
Percentile
P92
Near historical high
vs 3Y Ago
3.3x
Strong expansion
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
20253.71+237.1%
2024-2.71-102.7%
202398.48+8728.3%
20221.12-21.6%
20211.42+990.2%
2020-0.16-115.1%
20191.06+18.5%
20180.89+122.6%
2017-3.95-11558.4%
20160.03-